Merit Financial Group, LLC Takeda Pharmaceutical CO LTD Transaction History
Merit Financial Group, LLC
- $9.62 Billion
- Q3 2025
A detailed history of Merit Financial Group, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Merit Financial Group, LLC holds 21,178 shares of TAK stock, worth $284,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,178
Previous 18,232
16.16%
Holding current value
$284,632
Previous $281,000
10.32%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
379Shares Held
73.2MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$102 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$60.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$54.1 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$49.9 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...